Nat Prod Sci.  2018 Sep;24(3):206-212. 10.20307/nps.2018.24.3.206.

Simultaneous Determination of the Seven Phenylpropanoids in Xanthii Fructus Using a HPLC-PDA and LC-MS

Affiliations
  • 1Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. hkshin@kiom.re.kr

Abstract

Xanthii Fructus has been traditionally used for the treatment of rhinitis, rheumatoid arthritis, and eczema. In this study, a high-performance liquid chromatography-photodiode array (HPLC-PDA) method was developed and then used for the simultaneous analysis of eight phenylpropanoids in Xanthii Fructus. The analytical column used for this separation was a SunFireâ„¢ C₁₈ column, maintained at 40℃. The mobile phase used was 1.0% acetic acid in distilled water and 1.0% acetic acid in acetonitrile with gradient elution. For identify of each component, the mass spectrometer (MS) was used a Waters triple quadrupole mass spectrometer requipped with electrospray ionization (ESI) source. The HPLC-PDA method showed good linearity: correlation coefficients were ≥ 0.9996. The limits of detection and quantification of the eight compounds were 0.02 - 0.04 and 0.06 - 0.14 µg/mL, respectively. The extraction recoveries ranged from 97.51 to 108.67%. The relative standard deviation values of intra- and inter-day precision were 0.06 - 1.55 and 0.09 - 1.68%, respectively. The validated HPLC-PDA method was applied to simultaneously analyse the amounts of eight phenlypropanoids in Xanthii Fructus.

Keyword

Simultaneous; Determination; Xanthii Fructus; Phenylpropanoids; HPLC-PDA; LC-MS

MeSH Terms

Acetic Acid
Arthritis, Rheumatoid
Eczema
Limit of Detection
Methods
Rhinitis
Water
Acetic Acid
Water

Figure

  • Fig. 1 Chemical structures of eight marker compounds in XF.

  • Fig. 2 HPLC chromatograms of the standard solutions (A) and XF extract (B) at 325 nm. Identified compounds are (1) 3-CQA; (2) CA; (3) 1,4-DCQA; (4) 1,3-DCQA; (5) FA; (6) 1,5-DCQA; (7) 3,5-DCQA; and (8) 4,5-DCQA.

  • Fig. 3 Mass spectra of eight reference standard compounds. (A) 3-CQA; (B) CA; (C) 1,4-DCQA; (D) 1,3-DCQA; (E) FA; (F) 1,5-DCQA; (G) 3,5-DCQA; and (H) 4,5-DCQA.


Reference

1. Bae KH. The medicinal plants of Korea. Seoul: Kyo-Hak Publishing;2000. p. 514.
2. Shin SW, Lee JH, Bang KS. Korean J Plant Resour. 2012; 25:372–378.
3. Lee YM, Kang DG, Kim MG, Choi DH, Lee HS. Korean J Orient Physiol Pathol. 2004; 18:792–796.
4. Huang MH, Wang BS, Chiu CS, Amagaya S, Hsieh WT, Huang SS, Shie PH, Huang GJ. J Ethnopharmacol. 2011; 135:545–552.
5. Lin B, Zhao Y, Han P, Yue W, Ma XQ, Rahman K, Zheng CJ, Qin LP, Han T. J Ethnopharmacol. 2014; 155:248–255.
6. Peng W, Ming QL, Han P, Zhang QY, Jiang YP, Zheng CJ, Han T, Qin LP. Phytomedicine. 2014; 21:824–829.
7. Li H, Min YS, Park KC, Kim DS. Biosci Biotechnol Biochem. 2012; 76:767–771.
8. Ma YT, Huang MC, Hsu FL, Chang HF. Phytochemistry. 1998; 48:1083–1085.
9. Chen F, Hao F, Li C, Gou J, Lu D, Gong F, Tang H, Zhang Y. PLoS One. 2013; 8:e76621.
10. Nibret E, Youns M, Krauth-Siegel RL, Wink M. Phytother Res. 2011; 25:1883–1890.
11. Cheng Z, Wang L, Chen B, Li F, Wang M. Chin J Appl Environ Biol. 2011; 3:350–352.
12. Yang L, Su ZJ, Xu SJ, Wu JX, Chen LL, Zhou RL, Li X, Zeng X. Yao Xue Xue Bao. 2010; 45:1537–1540.
13. Jiang H, Yang L, Xing X, Yan M, Guo X, Yang B, Wang Q, Kuang H. Molecules. 2018; 23:243.
14. International Conference on Harmonisation. Guidance for industry, Q2B validation of analytical procedures: methodology. 1996.
Full Text Links
  • NPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr